Studies investigating RANKL levels in CKD patients have demonstrated conflicting findings (24–26), whereas OPG concentrations have consistently been reported to be higher in haemodialysis patients (24, 27, 28), which could reflect a compensatory protective mechanism to moderate bone remodelling. Here, TNFRSF11B is linked to chronic kidney disease.